{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:50:08Z","timestamp":1778759408290,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,26]],"date-time":"2011-03-26T00:00:00Z","timestamp":1301097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s12185-011-0812-0","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T02:09:18Z","timestamp":1301018958000},"page":"677-680","source":"Crossref","is-referenced-by-count":12,"title":["Autologous stem cell transplantation in a rare multicentric Castleman disease of the plasma cell variant"],"prefix":"10.1007","volume":"93","author":[{"given":"Yuval","family":"Tal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Haber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matan J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micci","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,26]]},"reference":[{"issue":"23","key":"812_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM195406102502308","volume":"250","author":"B Castleman","year":"1954","unstructured":"Castleman B, Towne VW. Case records of the Massachusetts General Hospital: Case No. 40231. N Engl J Med. 1954;250(23):1001\u20135.","journal-title":"N Engl J Med"},{"issue":"8","key":"812_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/02841860410002752","volume":"43","author":"A Waterston","year":"2004","unstructured":"Waterston A, Bower M. Fifty years of multicentric Castleman\u2019s disease. Acta Oncol. 2004;43(8):698\u2013704.","journal-title":"Acta Oncol"},{"issue":"3","key":"812_CR3","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q","volume":"92","author":"GM Chronowski","year":"2001","unstructured":"Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001;92(3):670\u20136.","journal-title":"Cancer"},{"issue":"6","key":"812_CR4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.0303-6987.2004.00117.x","volume":"31","author":"WM Klein","year":"2004","unstructured":"Klein WM, Rencic A, Munshi NC, Nousari CH. Multicentric plasma cell variant of Castleman\u2019s disease with cutaneous involvement. J Cutan Pathol. 2004;31(6):448\u201352.","journal-title":"J Cutan Pathol"},{"key":"812_CR5","doi-asserted-by":"crossref","unstructured":"Miltenyi Z, Toth J, Gonda A, Tar I, Remenyik E, Illes A. Successful immunomodulatory therapy in Castleman disease with paraneoplastic Pemphigus Vulgaris. Pathol Oncol Res. 2008.","DOI":"10.1007\/s12253-008-9133-x"},{"issue":"8","key":"812_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-128-8-199804150-00010","volume":"128","author":"J Herrada","year":"1998","unstructured":"Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657\u201362.","journal-title":"Ann Intern Med"},{"issue":"12","key":"812_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00277-003-0718-x","volume":"82","author":"D Gholam","year":"2003","unstructured":"Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH. A case of multicentric Castleman\u2019s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol. 2003;82(12):766\u20138.","journal-title":"Ann Hematol"},{"issue":"4","key":"812_CR8","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ajh.20283","volume":"78","author":"EM Ocio","year":"2005","unstructured":"Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, et al. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol. 2005;78(4):302\u20135.","journal-title":"Am J Hematol"},{"issue":"9","key":"812_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1056\/NEJM199403033300904","volume":"330","author":"JT Beck","year":"1994","unstructured":"Beck JT, Hsu SM, Wijdenes J, et al. Brief report: alleviation of systemic manifestations of Castleman\u2019s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994;330(9):602\u20135.","journal-title":"N Engl J Med"},{"key":"812_CR10","doi-asserted-by":"crossref","first-page":"897a","DOI":"10.1182\/blood.V104.11.897.897","volume":"104","author":"F Rhee van","year":"2004","unstructured":"van Rhee F, Alikhan M, Munshi N, et al. Anti-IL6 antibody (ab) based strategies improve the management of HIV negative Castleman\u2019s disease. Blood. 2004;104:897a.","journal-title":"Blood"},{"issue":"6","key":"812_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3324\/haematol.10794","volume":"92","author":"H Kawabata","year":"2007","unstructured":"Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman\u2019s disease. Haematologica. 2007;92(6):857\u20138.","journal-title":"Haematologica"},{"issue":"8","key":"812_CR12","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106(8):2627\u201332.","journal-title":"Blood"},{"issue":"1","key":"812_CR13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V95.1.56","volume":"95","author":"N Nishimoto","year":"2000","unstructured":"Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman\u2019s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95(1):56\u201361.","journal-title":"Blood"},{"issue":"10","key":"812_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1023\/A:1008366721816","volume":"10","author":"R Advani","year":"1999","unstructured":"Advani R, Warnke R, Rosenberg S. Treatment of multicentric Castleman\u2019s disease complicated by the development of non-Hodgkin\u2019s lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. Ann Oncol. 1999;10(10):1207\u20139.","journal-title":"Ann Oncol"},{"issue":"3","key":"812_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5414\/CNP68171","volume":"68","author":"M Ogita","year":"2007","unstructured":"Ogita M, Hoshino J, Sogawa Y, et al. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation. Clin Nephrol. 2007;68(3):171\u20136.","journal-title":"Clin Nephrol"},{"issue":"3","key":"812_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/hon.2900040305","volume":"4","author":"L Repetto","year":"1986","unstructured":"Repetto L, Jaiprakash MP, Selby PJ, Gusterson BA, Williams HJ, McElwain TJ. Aggressive angiofollicular lymph node hyperplasia (Castleman\u2019s disease) treated with high dose melphalan and autologous bone marrow transplantation. Hematol Oncol. 1986;4(3):213\u20137.","journal-title":"Hematol Oncol"},{"issue":"10","key":"812_CR17","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","volume":"104","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104(10):3400\u20137.","journal-title":"Blood"},{"issue":"3","key":"812_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ajh.20280","volume":"79","author":"AK Ganti","year":"2005","unstructured":"Ganti AK, Pipinos I, Culcea E, Armitage JO, Tarantolo S. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome. Am J Hematol. 2005;79(3):206\u201310.","journal-title":"Am J Hematol"},{"issue":"3","key":"812_CR19","first-page":"172","volume":"10","author":"M Halac","year":"2007","unstructured":"Halac M, Ergul N, Sager S, Demir A, Buyukpinarbasli N, Sonmezoglu K. PET\/CT findings in a multicentric form of Castleman\u2019s disease. Hell J Nucl Med. 2007;10(3):172\u20134.","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"812_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1157\/13097380","volume":"26","author":"A Iagaru","year":"2007","unstructured":"Iagaru A, Mari C, Sam Gambhir S. Follicular dendritic sarcoma within a focus of Castleman\u2019s disease. Serial FDG PET\/CT in the follow up of recurrence with histopathologic confirmation. Rev Esp Med Nucl. 2007;26(1):40\u20135.","journal-title":"Rev Esp Med Nucl"},{"key":"812_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1752-1947-2-99","volume":"2","author":"E Pelosi","year":"2008","unstructured":"Pelosi E, Skanjeti A, Cistaro A, Arena V. Fluorodeoxyglucose-positron emission tomography\/computed tomography in the staging and evaluation of treatment response in a patient with Castleman\u2019s disease: a case report. J Med Case Rep. 2008;2:99.","journal-title":"J Med Case Rep"},{"issue":"4","key":"812_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.rlu.0000257288.11595.32","volume":"32","author":"CD Ramos","year":"2007","unstructured":"Ramos CD, Massumoto CM, Rosa MF, et al. Focal bone marrow involvement in multicentric Castleman disease demonstrated by FDG PET\/CT. Clin Nucl Med. 2007;32(4):295\u20136.","journal-title":"Clin Nucl Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0812-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-011-0812-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0812-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-011-0812-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T15:24:59Z","timestamp":1592407499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-011-0812-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,26]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1007\/s12185-011-0812-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,26]]}}}